Christin Melton

More Rigorous Studies Needed to Assess Use of Advanced Access Scheduling in Primary Care
09/19/2011
An analysis of published English-language studies on advanced access (AA) scheduling in the primary care setting revealed mixed results [Arch Intern Med. 2011;171(13):1150-1159]. Although wait times for an appointment typically decreased, as...
An analysis of published English-language studies on advanced access (AA) scheduling in the primary care setting revealed mixed results [Arch Intern Med. 2011;171(13):1150-1159]. Although wait times for an appointment typically decreased, as...
An analysis of published...
09/19/2011
First Report Managed Care
Feature
Investigators Update 2-Year Data on Safinamide Use in Parkinson’s Disease Patients
07/19/2011
Honolulu—A 2-year trial of patients with Parkinson’s disease (PD) and motor fluctuations found the addition of daily safinamide increased the amount of time each day in which patients experienced symptom relief with levodopa (ON time) and...
Honolulu—A 2-year trial of patients with Parkinson’s disease (PD) and motor fluctuations found the addition of daily safinamide increased the amount of time each day in which patients experienced symptom relief with levodopa (ON time) and...
Honolulu—A 2-year trial of...
07/19/2011
First Report Managed Care
Linaclotide Found to Reduce Unpleasant Effects of Chronic Constipation
10/14/2011
In 2 placebo-controlled phase 3 trials, a 12-week daily regimen of linaclotide significantly reduced symptoms of chronic constipation and improved quality of life. Study investigators said the ameliorating effects of linaclotide were evident...
In 2 placebo-controlled phase 3 trials, a 12-week daily regimen of linaclotide significantly reduced symptoms of chronic constipation and improved quality of life. Study investigators said the ameliorating effects of linaclotide were evident...
In 2 placebo-controlled phase 3...
10/14/2011
First Report Managed Care
Surgical Intervention Not Always Needed for Pneumatosis Intestinalis
08/23/2011
Pneumatosis intestinalis (PI), a potentially fatal occurrence, is often treated surgically, but new data from a retrospective study suggest many patients with PI are good candidates for nonoperative management. Investigators for the study,...
Pneumatosis intestinalis (PI), a potentially fatal occurrence, is often treated surgically, but new data from a retrospective study suggest many patients with PI are good candidates for nonoperative management. Investigators for the study,...
Pneumatosis intestinalis (PI), a...
08/23/2011
First Report Managed Care
Feature
Fingolimod Reduces Likelihood and Severity of Relapse in MS Patients
07/19/2011
Honolulu—An analysis of data from two phase 3 studies, presented at a poster session during the AAN meeting, found oral fingolimod more effective at preventing relapse in patients with multiple sclerosis (MS) than interferon beta-1a or...
Honolulu—An analysis of data from two phase 3 studies, presented at a poster session during the AAN meeting, found oral fingolimod more effective at preventing relapse in patients with multiple sclerosis (MS) than interferon beta-1a or...
Honolulu—An analysis of data...
07/19/2011
First Report Managed Care
Proton Pump Inhibitors May Compromise Antifracture Efficacy of Alendronate in Elderly Patients
10/14/2011
Elderly patients who receive proton pump inhibitors (PPIs) while using alendronate, an oral bisphosphonate typically prescribed to reduce the risk of osteoporotic fractures, may have poorer response to alendronate. According to a...
Elderly patients who receive proton pump inhibitors (PPIs) while using alendronate, an oral bisphosphonate typically prescribed to reduce the risk of osteoporotic fractures, may have poorer response to alendronate. According to a...
Elderly patients who receive...
10/14/2011
First Report Managed Care
Sirolimus-Eluting Stents versus CABG in Unprotected Left Main Coronary Stenosis
08/23/2011
A Korean study found percutaneous coronary intervention with sirolimus-eluting stents noninferior to coronary artery bypass grafting in patients.
A Korean study found percutaneous coronary intervention with sirolimus-eluting stents noninferior to coronary artery bypass grafting in patients.
A Korean study found...
08/23/2011
First Report Managed Care
Feature
Novel MS Drug Reduces Relapse Risk in All Subgroups
07/19/2011
Honolulu—The investigational drug teriflunomide demonstrated consistent reductions in rates of relapse and disease progression among patients with relapsing-remitting multiple sclerosis (MS), independent of patient demographics and disease...
Honolulu—The investigational drug teriflunomide demonstrated consistent reductions in rates of relapse and disease progression among patients with relapsing-remitting multiple sclerosis (MS), independent of patient demographics and disease...
Honolulu—The investigational...
07/19/2011
First Report Managed Care
BEACOPP and ABVD Regimens in Patients with Advanced Hodgkin Lymphoma
10/14/2011
Should an intensive BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) regimen replace the commonly used ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) regimen as front-line...
Should an intensive BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) regimen replace the commonly used ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) regimen as front-line...
Should an intensive BEACOPP...
10/14/2011
First Report Managed Care
Immunologic Fecal Occult Blood Testing Effective Screening Tool for Advanced Colorectal Cancer
08/22/2011
Chicago—Fecal occult blood testing is routinely used to screen for colorectal cancer (CRC), and multiple methods are available. A team of Italian researchers assessed the effectiveness of immunologic fecal occult blood testing (FIT) at...
Chicago—Fecal occult blood testing is routinely used to screen for colorectal cancer (CRC), and multiple methods are available. A team of Italian researchers assessed the effectiveness of immunologic fecal occult blood testing (FIT) at...
Chicago—Fecal occult blood...
08/22/2011
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use